Gait Abnormalities in Children with Phelan-McDermid Syndrome.

IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Journal of Child Neurology Pub Date : 2023-12-01 Epub Date: 2023-10-18 DOI:10.1177/08830738231204395
Yitzchak Frank, Tess Levy, Reymundo Lozano, Kate Friedman, Slayton Underwood, Ana Kostic, Hannah Walker, Alexander Kolevzon
{"title":"Gait Abnormalities in Children with Phelan-McDermid Syndrome.","authors":"Yitzchak Frank, Tess Levy, Reymundo Lozano, Kate Friedman, Slayton Underwood, Ana Kostic, Hannah Walker, Alexander Kolevzon","doi":"10.1177/08830738231204395","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Phelan-McDermid syndrome is a genetic disorder caused by haploinsufficiency of the <i>SHANK3</i> gene on chromosome 22q13.3 and is characterized by autism spectrum disorder, intellectual disability, speech and language abnormalities, hypotonia, and mild dysmorphic features. Early literature in Phelan-McDermid syndrome did not include gait abnormalities as part of the syndrome although recent prospective studies report that the prevalence of gait abnormalities ranges from 55% to 94%. We compared gait abnormalities in individuals with Phelan-McDermid syndrome, idiopathic autism spectrum disorder, and typically developing controls, and explored associations between gait abnormalities, autism spectrum disorder, and intellectual functioning. <b>Method:</b> The study cohort consists of 67 participants between the ages of 3 and 18 years, divided into 3 groups: Phelan-McDermid syndrome (n  =  46), idiopathic autism spectrum disorder (n  =  11), and typically developing controls (n  =  10). Gait was recorded using a video camera and scored across 26 gait features using a \"Gait Clinical Observations scale\" designed specifically for this study. <b>Results:</b> Gait abnormalities were significantly higher in the Phelan-McDermid syndrome group as compared to idiopathic autism spectrum disorder or typically developing controls. The number of gait abnormalities across groups was also significantly correlated with Intellectual Quotient/Developmental Quotient (IQ/DQ). In analysis of covariance including IQ/DQ, the effect of group was not significant, but the effect of IQ/DQ was significant. <b>Conclusions:</b> Overall differences in gait abnormalities were determined by the degree of intellectual disability, which was significantly higher in Phelan-McDermid syndrome.</p>","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"665-671"},"PeriodicalIF":2.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Child Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/08830738231204395","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Phelan-McDermid syndrome is a genetic disorder caused by haploinsufficiency of the SHANK3 gene on chromosome 22q13.3 and is characterized by autism spectrum disorder, intellectual disability, speech and language abnormalities, hypotonia, and mild dysmorphic features. Early literature in Phelan-McDermid syndrome did not include gait abnormalities as part of the syndrome although recent prospective studies report that the prevalence of gait abnormalities ranges from 55% to 94%. We compared gait abnormalities in individuals with Phelan-McDermid syndrome, idiopathic autism spectrum disorder, and typically developing controls, and explored associations between gait abnormalities, autism spectrum disorder, and intellectual functioning. Method: The study cohort consists of 67 participants between the ages of 3 and 18 years, divided into 3 groups: Phelan-McDermid syndrome (n  =  46), idiopathic autism spectrum disorder (n  =  11), and typically developing controls (n  =  10). Gait was recorded using a video camera and scored across 26 gait features using a "Gait Clinical Observations scale" designed specifically for this study. Results: Gait abnormalities were significantly higher in the Phelan-McDermid syndrome group as compared to idiopathic autism spectrum disorder or typically developing controls. The number of gait abnormalities across groups was also significantly correlated with Intellectual Quotient/Developmental Quotient (IQ/DQ). In analysis of covariance including IQ/DQ, the effect of group was not significant, but the effect of IQ/DQ was significant. Conclusions: Overall differences in gait abnormalities were determined by the degree of intellectual disability, which was significantly higher in Phelan-McDermid syndrome.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Phelan-McDermid综合征患儿的步态异常。
背景:Phelan-McDermid综合征是一种由染色体22q13.3上SHANK3基因单倍缺失引起的遗传性疾病,以自闭症谱系障碍、智力残疾、言语和语言异常、张力减退和轻度畸形为特征。Phelan-McDermid综合征的早期文献没有将步态异常作为综合征的一部分,尽管最近的前瞻性研究报告步态异常的患病率在55%至94%之间。我们比较了Phelan-McDermid综合征、特发性自闭症谱系障碍和典型对照组的步态异常,并探讨了步态异常、自闭症谱系疾病和智力功能之间的关系。方法:研究队列由67名年龄在3岁至18岁之间的参与者组成,分为3组:费兰-麦克德米德综合征(Phelan-McDermid syndrome  =  46),特发性自闭症谱系障碍(n  =  11) ,并且通常开发控件(n  =  10) 。使用摄像机记录步态,并使用专门为本研究设计的“步态临床观察量表”对26个步态特征进行评分。结果:Phelan-McDermid综合征组的步态异常明显高于特发性自闭症谱系障碍或典型发展对照组。各组步态异常的数量也与智力商/发育商(IQ/DQ)显著相关。在包括IQ/DQ在内的协方差分析中,组的影响不显著,但IQ/DQ的影响显著。结论:步态异常的总体差异由智力残疾程度决定,Phelan-McDermid综合征的智力残疾程度明显更高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Child Neurology
Journal of Child Neurology 医学-临床神经学
CiteScore
4.20
自引率
5.30%
发文量
111
审稿时长
3-6 weeks
期刊介绍: The Journal of Child Neurology (JCN) embraces peer-reviewed clinical and investigative studies from a wide-variety of neuroscience disciplines. Focusing on the needs of neurologic patients from birth to age 18 years, JCN covers topics ranging from assessment of new and changing therapies and procedures; diagnosis, evaluation, and management of neurologic, neuropsychiatric, and neurodevelopmental disorders; and pathophysiology of central nervous system diseases.
期刊最新文献
Anti-CD20 Therapy in Children With Severe Epstein-Barr Virus-Associated Meningoencephalitis. First-Drug Efficacy and Drug-Resistant Epilepsy Rates in Children With New-Onset Epilepsies: A Multicenter Large Cohort Study. Hammersmith Neonatal and Infant Neurological Examinations Scores in Typically Developing Infants Aged 1-6 Months. Determination of Health Concepts in β-Propeller Protein-Associated Neurodegeneration. The Initial Experience of Eslicarbazepine in Children at Three Canadian Tertiary Pediatric Care Centers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1